// Autonomic Nervous System - Drugs
// Auto-generated from modularize-data.js

const drugs = [

    {
        "id": "bethanechol",
        "name": "Bethanechol",
        "pharmacologicClass": "direct-muscarinic-agonists",
        "therapeuticClass": "cholinergic-agonists-parasympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Direct stimulation of muscarinic receptors, mimicking acetylcholine effects.",
        "features": "Selective for M3 receptors.",
        "clinicalChoice": "Postoperative urinary retention.",
        "indications": [
            "Urinary Retention",
            "Gastroparesis"
        ],
        "contraindications": [
            "Asthma",
            "COPD",
            "Mechanical Obstruction"
        ],
        "sideEffects": [
            "Cholinergic crisis",
            "Bradycardia",
            "Hypotension",
            "Bronchoconstriction"
        ],
        "interactions": "Anticholinergics antagonize effects.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "pilocarpine",
        "name": "Pilocarpine",
        "pharmacologicClass": "direct-muscarinic-agonists",
        "therapeuticClass": "cholinergic-agonists-parasympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Direct stimulation of muscarinic receptors, mimicking acetylcholine effects.",
        "features": "Crosses blood-brain barrier.",
        "clinicalChoice": "Glaucoma, xerostomia.",
        "indications": [
            "Glaucoma",
            "Dry Mouth"
        ],
        "contraindications": [
            "Narrow-angle Glaucoma",
            "Asthma"
        ],
        "sideEffects": [
            "Cholinergic crisis",
            "Bradycardia",
            "Hypotension",
            "Bronchoconstriction"
        ],
        "interactions": "Anticholinergics antagonize effects.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "carbachol",
        "name": "Carbachol",
        "pharmacologicClass": "direct-muscarinic-agonists",
        "therapeuticClass": "cholinergic-agonists-parasympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Direct stimulation of muscarinic receptors, mimicking acetylcholine effects.",
        "features": "Resistant to AChE, strong nicotinic activity.",
        "clinicalChoice": "Pupil constriction for glaucoma.",
        "indications": [
            "Glaucoma",
            "Miosis Induction"
        ],
        "contraindications": [
            "Asthma",
            "COPD"
        ],
        "sideEffects": [
            "Cholinergic crisis",
            "Bradycardia",
            "Hypotension",
            "Bronchoconstriction"
        ],
        "interactions": "Anticholinergics antagonize effects.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "methacholine",
        "name": "Methacholine",
        "pharmacologicClass": "direct-muscarinic-agonists",
        "therapeuticClass": "cholinergic-agonists-parasympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Direct stimulation of muscarinic receptors, mimicking acetylcholine effects.",
        "features": "Potent muscarinic agonist, short-acting.",
        "clinicalChoice": "Bronchial hyperreactivity challenge test.",
        "indications": [
            "Asthma Diagnosis"
        ],
        "contraindications": [
            "Severe Asthma",
            "Recent MI",
            "Arrhythmia"
        ],
        "sideEffects": [
            "Cholinergic crisis",
            "Bradycardia",
            "Hypotension",
            "Bronchoconstriction"
        ],
        "interactions": "Anticholinergics antagonize effects.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "neostigmine",
        "name": "Neostigmine",
        "pharmacologicClass": "acetylcholinesterase-inhibitors",
        "therapeuticClass": "cholinergic-agonists-parasympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Inhibit breakdown of acetylcholine, increasing cholinergic transmission.",
        "features": "Does not cross BBB.",
        "clinicalChoice": "Reversal of neuromuscular blockade.",
        "indications": [
            "Myasthenia Gravis",
            "Neuromuscular Blockade Reversal"
        ],
        "contraindications": [
            "Mechanical Obstruction"
        ],
        "sideEffects": [
            "Cholinergic crisis",
            "Muscle weakness",
            "Bradycardia"
        ],
        "interactions": "Succinylcholine effects prolonged.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "physostigmine",
        "name": "Physostigmine",
        "pharmacologicClass": "acetylcholinesterase-inhibitors",
        "therapeuticClass": "cholinergic-agonists-parasympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Inhibit breakdown of acetylcholine, increasing cholinergic transmission.",
        "features": "Crosses blood-brain barrier.",
        "clinicalChoice": "Anticholinergic poisoning antidote.",
        "indications": [
            "Anticholinergic Toxicity"
        ],
        "contraindications": [
            "Asthma",
            "Mechanical Obstruction"
        ],
        "sideEffects": [
            "Cholinergic crisis",
            "Muscle weakness",
            "Bradycardia"
        ],
        "interactions": "Succinylcholine effects prolonged.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "pyridostigmine",
        "name": "Pyridostigmine",
        "pharmacologicClass": "acetylcholinesterase-inhibitors",
        "therapeuticClass": "cholinergic-agonists-parasympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Inhibit breakdown of acetylcholine, increasing cholinergic transmission.",
        "features": "Longer duration than neostigmine.",
        "clinicalChoice": "Chronic myasthenia gravis treatment.",
        "indications": [
            "Myasthenia Gravis"
        ],
        "contraindications": [
            "Mechanical Obstruction"
        ],
        "sideEffects": [
            "Cholinergic crisis",
            "Muscle weakness",
            "Bradycardia"
        ],
        "interactions": "Succinylcholine effects prolonged.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "edrophonium",
        "name": "Edrophonium",
        "pharmacologicClass": "acetylcholinesterase-inhibitors",
        "therapeuticClass": "cholinergic-agonists-parasympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Inhibit breakdown of acetylcholine, increasing cholinergic transmission.",
        "features": "Very short-acting AChE inhibitor.",
        "clinicalChoice": "Tensilon test to diagnose myasthenia gravis.",
        "indications": [
            "Myasthenia Diagnosis"
        ],
        "contraindications": [
            "Asthma",
            "Mechanical Obstruction"
        ],
        "sideEffects": [
            "Cholinergic crisis",
            "Muscle weakness",
            "Bradycardia"
        ],
        "interactions": "Succinylcholine effects prolonged.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "donepezil",
        "name": "Donepezil",
        "pharmacologicClass": "acetylcholinesterase-inhibitors",
        "therapeuticClass": "cholinergic-agonists-parasympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Inhibit breakdown of acetylcholine, increasing cholinergic transmission.",
        "features": "Lipophilic, CNS penetration.",
        "clinicalChoice": "Alzheimer disease symptomatic therapy.",
        "indications": [
            "Alzheimer Disease"
        ],
        "contraindications": [
            "Bradycardia",
            "Heart Block"
        ],
        "sideEffects": [
            "Cholinergic crisis",
            "Muscle weakness",
            "Bradycardia"
        ],
        "interactions": "Succinylcholine effects prolonged.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "rivastigmine",
        "name": "Rivastigmine",
        "pharmacologicClass": "acetylcholinesterase-inhibitors",
        "therapeuticClass": "cholinergic-agonists-parasympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Inhibit breakdown of acetylcholine, increasing cholinergic transmission.",
        "features": "Transdermal option, less hepatic metabolism.",
        "clinicalChoice": "Dementia with parkinsonism.",
        "indications": [
            "Alzheimer Disease",
            "Parkinson Dementia"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "sideEffects": [
            "Cholinergic crisis",
            "Muscle weakness",
            "Bradycardia"
        ],
        "interactions": "Succinylcholine effects prolonged.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "galantamine",
        "name": "Galantamine",
        "pharmacologicClass": "acetylcholinesterase-inhibitors",
        "therapeuticClass": "cholinergic-agonists-parasympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Inhibit breakdown of acetylcholine, increasing cholinergic transmission.",
        "features": "Also modulates nicotinic receptors.",
        "clinicalChoice": "Alzheimer disease mild-to-moderate.",
        "indications": [
            "Alzheimer Disease"
        ],
        "contraindications": [
            "Severe Hepatic Impairment"
        ],
        "sideEffects": [
            "Cholinergic crisis",
            "Muscle weakness",
            "Bradycardia"
        ],
        "interactions": "Succinylcholine effects prolonged.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "atropine",
        "name": "Atropine",
        "pharmacologicClass": "muscarinic-antagonists",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block muscarinic receptors, preventing acetylcholine effects.",
        "features": "Crosses BBB, systemic effects.",
        "clinicalChoice": "Bradycardia, organophosphate poisoning.",
        "indications": [
            "Bradycardia",
            "Organophosphate Poisoning"
        ],
        "contraindications": [
            "Narrow-angle Glaucoma",
            "BPH"
        ],
        "sideEffects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention",
            "Confusion"
        ],
        "interactions": "Other anticholinergics (additive effects).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "scopolamine",
        "name": "Scopolamine",
        "pharmacologicClass": "muscarinic-antagonists",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block muscarinic receptors, preventing acetylcholine effects.",
        "features": "High CNS penetration.",
        "clinicalChoice": "Motion sickness prevention.",
        "indications": [
            "Motion Sickness",
            "Postoperative Nausea"
        ],
        "contraindications": [
            "Narrow-angle Glaucoma"
        ],
        "sideEffects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention",
            "Confusion"
        ],
        "interactions": "Other anticholinergics (additive effects).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "ipratropium",
        "name": "Ipratropium",
        "pharmacologicClass": "anticholinergics",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block muscarinic receptors, preventing acetylcholine effects.",
        "features": "Quaternary ammonium, minimal systemic absorption. | Short-acting muscarinic antagonist.",
        "clinicalChoice": "COPD bronchodilation.",
        "indications": [
            "Asthma",
            "COPD"
        ],
        "contraindications": [
            "Soy/Peanut Allergy"
        ],
        "sideEffects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention",
            "Confusion"
        ],
        "interactions": "Other anticholinergics (additive effects).",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "anticholinergics",
            "muscarinic-antagonists"
        ]
    },
    {
        "id": "tiotropium",
        "name": "Tiotropium",
        "pharmacologicClass": "anticholinergics",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block muscarinic receptors, preventing acetylcholine effects.",
        "features": "Once-daily LAMA. | Once-daily long-acting anticholinergic.",
        "clinicalChoice": "COPD maintenance therapy.",
        "indications": [
            "COPD"
        ],
        "contraindications": [
            "Narrow-angle Glaucoma"
        ],
        "sideEffects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention",
            "Confusion"
        ],
        "interactions": "Other anticholinergics (additive effects).",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "anticholinergics",
            "muscarinic-antagonists"
        ]
    },
    {
        "id": "benztropine",
        "name": "Benztropine",
        "pharmacologicClass": "muscarinic-antagonists",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block muscarinic receptors, preventing acetylcholine effects.",
        "features": "Central acting M1 antagonist.",
        "clinicalChoice": "Parkinson tremor and dystonia.",
        "indications": [
            "Parkinson Disease",
            "Acute Dystonia"
        ],
        "contraindications": [
            "Narrow-angle Glaucoma",
            "Tardive Dyskinesia"
        ],
        "sideEffects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention",
            "Confusion"
        ],
        "interactions": "Other anticholinergics (additive effects).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "trihexyphenidyl",
        "name": "Trihexyphenidyl",
        "pharmacologicClass": "muscarinic-antagonists",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block muscarinic receptors, preventing acetylcholine effects.",
        "features": "Central antimuscarinic similar to benztropine.",
        "clinicalChoice": "Adjunct therapy for Parkinsonism.",
        "indications": [
            "Parkinson Disease"
        ],
        "contraindications": [
            "Narrow-angle Glaucoma",
            "Prostatic Hypertrophy"
        ],
        "sideEffects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention",
            "Confusion"
        ],
        "interactions": "Other anticholinergics (additive effects).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "glycopyrrolate",
        "name": "Glycopyrrolate",
        "pharmacologicClass": "muscarinic-antagonists",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block muscarinic receptors, preventing acetylcholine effects.",
        "features": "Quaternary, no CNS penetration.",
        "clinicalChoice": "Preoperative secretion control, IBS.",
        "indications": [
            "Peptic Ulcer Adjunct",
            "Excess Drooling"
        ],
        "contraindications": [
            "Severe Ulcerative Colitis"
        ],
        "sideEffects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention",
            "Confusion"
        ],
        "interactions": "Other anticholinergics (additive effects).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "oxybutynin",
        "name": "Oxybutynin",
        "pharmacologicClass": "muscarinic-antagonists",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block muscarinic receptors, preventing acetylcholine effects.",
        "features": "Selective for bladder M3 receptors.",
        "clinicalChoice": "Urge urinary incontinence.",
        "indications": [
            "Overactive Bladder"
        ],
        "contraindications": [
            "Urinary Retention",
            "Gastric Retention"
        ],
        "sideEffects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention",
            "Confusion"
        ],
        "interactions": "Other anticholinergics (additive effects).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "tolterodine",
        "name": "Tolterodine",
        "pharmacologicClass": "muscarinic-antagonists",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block muscarinic receptors, preventing acetylcholine effects.",
        "features": "Bladder-selective antimuscarinic.",
        "clinicalChoice": "Chronic overactive bladder.",
        "indications": [
            "Overactive Bladder"
        ],
        "contraindications": [
            "Urinary Retention"
        ],
        "sideEffects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention",
            "Confusion"
        ],
        "interactions": "Other anticholinergics (additive effects).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "homatropine-tropicamide",
        "name": "Homatropine/Tropicamide",
        "pharmacologicClass": "muscarinic-antagonists",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block muscarinic receptors, preventing acetylcholine effects.",
        "features": "Short-acting mydriatics.",
        "clinicalChoice": "Mydriasis for eye exams.",
        "indications": [
            "Ophthalmic Dilation"
        ],
        "contraindications": [
            "Narrow-angle Glaucoma"
        ],
        "sideEffects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention",
            "Confusion"
        ],
        "interactions": "Other anticholinergics (additive effects).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "dicyclomine",
        "name": "Dicyclomine",
        "pharmacologicClass": "muscarinic-antagonists",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block muscarinic receptors, preventing acetylcholine effects.",
        "features": "GI-selective antispasmodic.",
        "clinicalChoice": "Irritable bowel syndrome cramping.",
        "indications": [
            "IBS"
        ],
        "contraindications": [
            "Severe Ulcerative Colitis",
            "Obstructive Uropathy"
        ],
        "sideEffects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention",
            "Confusion"
        ],
        "interactions": "Other anticholinergics (additive effects).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "hyoscyamine",
        "name": "Hyoscyamine",
        "pharmacologicClass": "muscarinic-antagonists",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block muscarinic receptors, preventing acetylcholine effects.",
        "features": "GI antispasmodic, sublingual option.",
        "clinicalChoice": "Adjunct for IBS symptom control.",
        "indications": [
            "IBS"
        ],
        "contraindications": [
            "Narrow-angle Glaucoma"
        ],
        "sideEffects": [
            "Dry mouth",
            "Constipation",
            "Urinary retention",
            "Confusion"
        ],
        "interactions": "Other anticholinergics (additive effects).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "succinylcholine",
        "name": "Succinylcholine",
        "pharmacologicClass": "neuromuscular-blocking-agents",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block nicotinic receptors at neuromuscular junction or ganglia.",
        "features": "Depolarizing blocker, fasciculations. | Depolarizing blocker, rapid onset/offset.",
        "clinicalChoice": "Rapid sequence intubation.",
        "indications": [
            "Neuromuscular Blockade",
            "Rapid Sequence Intubation"
        ],
        "contraindications": [
            "Malignant Hyperthermia",
            "Hyperkalemia"
        ],
        "sideEffects": [
            "Muscle weakness",
            "Paralysis",
            "Ganglionic blockade"
        ],
        "interactions": "Aminoglycosides potentiate blockade.",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "neuromuscular-blocking-agents",
            "nicotinic-antagonists"
        ]
    },
    {
        "id": "rocuronium",
        "name": "Rocuronium",
        "pharmacologicClass": "nicotinic-antagonists",
        "therapeuticClass": "cholinergic-antagonists-parasympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block nicotinic receptors at neuromuscular junction or ganglia.",
        "features": "Non-depolarizing, reversible.",
        "clinicalChoice": "Surgical paralysis.",
        "indications": [
            "Neuromuscular Blockade"
        ],
        "contraindications": [
            "Myasthenia Gravis"
        ],
        "sideEffects": [
            "Muscle weakness",
            "Paralysis",
            "Ganglionic blockade"
        ],
        "interactions": "Aminoglycosides potentiate blockade.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "epinephrine",
        "name": "Epinephrine",
        "pharmacologicClass": "mixed-α-β-agonists",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Stimulate both alpha and beta adrenergic receptors.",
        "features": "Potent α1, β1, β2 agonist.",
        "clinicalChoice": "Anaphylaxis, cardiac arrest.",
        "indications": [
            "Anaphylaxis",
            "Cardiac Arrest",
            "Asthma"
        ],
        "contraindications": [
            "Narrow-angle Glaucoma"
        ],
        "sideEffects": [
            "Hypertension",
            "Tachycardia",
            "Arrhythmias"
        ],
        "interactions": "MAOIs potentiate effects.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "norepinephrine",
        "name": "Norepinephrine",
        "pharmacologicClass": "mixed-α-β-agonists",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Stimulate both alpha and beta adrenergic receptors.",
        "features": "Potent α1, β1, minimal β2.",
        "clinicalChoice": "Septic shock, hypotension.",
        "indications": [
            "Shock",
            "Hypotension"
        ],
        "contraindications": [
            "Hypovolemia"
        ],
        "sideEffects": [
            "Hypertension",
            "Tachycardia",
            "Arrhythmias"
        ],
        "interactions": "MAOIs potentiate effects.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "dopamine",
        "name": "Dopamine",
        "pharmacologicClass": "dopamine-receptor-agonists",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Dose-dependent stimulation of dopamine, β1, and α1 receptors.",
        "features": "Low dose renal vasodilation, high dose α1.",
        "clinicalChoice": "Unstable bradycardia, cardiogenic shock.",
        "indications": [
            "Shock",
            "Heart Failure"
        ],
        "contraindications": [
            "Pheochromocytoma",
            "Tachyarrhythmias"
        ],
        "sideEffects": [
            "Arrhythmias",
            "Tachycardia",
            "Extravasation injury"
        ],
        "interactions": "MAOIs and β-blockers modify response.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "dobutamine",
        "name": "Dobutamine",
        "pharmacologicClass": "β1-selective-agonists",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Preferential stimulation of β1 receptors increases inotropy and chronotropy.",
        "features": "Predominantly β1 with mild β2/α1 activity.",
        "clinicalChoice": "Acute decompensated heart failure.",
        "indications": [
            "Heart Failure",
            "Cardiac Stress Testing"
        ],
        "contraindications": [
            "Idiopathic Hypertrophic Subaortic Stenosis"
        ],
        "sideEffects": [
            "Tachyarrhythmias",
            "Angina",
            "Hypertension"
        ],
        "interactions": "Beta-blockers blunt effects.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "isoproterenol",
        "name": "Isoproterenol",
        "pharmacologicClass": "non-selective-β-agonists",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Stimulate both β1 and β2 receptors strongly.",
        "features": "Powerful β1/β2 agonist, minimal α activity.",
        "clinicalChoice": "Refractory bradycardia with torsades from long QT.",
        "indications": [
            "Bradycardia",
            "Torsades de Pointes"
        ],
        "contraindications": [
            "Tachyarrhythmias"
        ],
        "sideEffects": [
            "Tachycardia",
            "Arrhythmias",
            "Hypotension from β2 vasodilation"
        ],
        "interactions": "Beta-blockers antagonize effects.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "albuterol",
        "name": "Albuterol",
        "pharmacologicClass": "selective-β2-agonists",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Selective stimulation of β2 receptors causing bronchodilation.",
        "features": "Short-acting, rescue medication. | Rapid onset, 4-6 hour duration, short-acting rescue medication.",
        "clinicalChoice": "Acute bronchospasm.",
        "indications": [
            "Asthma",
            "COPD",
            "Exercise-Induced Bronchospasm"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "sideEffects": [
            "Tachycardia",
            "Tremor",
            "Hypokalemia"
        ],
        "interactions": "Beta-blockers antagonize effects.",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "selective-β2-agonists",
            "short-acting-beta-2-agonists-saba"
        ]
    },
    {
        "id": "salmeterol",
        "name": "Salmeterol",
        "pharmacologicClass": "long-acting-beta-2-agonists-laba",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Selective stimulation of β2 receptors causing bronchodilation.",
        "features": "Long-acting, maintenance therapy. | Twice-daily dosing.",
        "clinicalChoice": "Asthma controller (with ICS).",
        "indications": [
            "Asthma",
            "COPD"
        ],
        "contraindications": [
            "Asthma Monotherapy"
        ],
        "sideEffects": [
            "Tachycardia",
            "Tremor",
            "Hypokalemia"
        ],
        "interactions": "Beta-blockers antagonize effects.",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "long-acting-beta-2-agonists-laba",
            "selective-β2-agonists"
        ]
    },
    {
        "id": "formoterol",
        "name": "Formoterol",
        "pharmacologicClass": "long-acting-beta-2-agonists-laba",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Selective stimulation of β2 receptors causing bronchodilation.",
        "features": "Long-acting with rapid onset. | Rapid onset for a LABA.",
        "clinicalChoice": "COPD maintenance therapy.",
        "indications": [
            "Asthma",
            "COPD"
        ],
        "contraindications": [
            "Asthma Monotherapy"
        ],
        "sideEffects": [
            "Tachycardia",
            "Tremor",
            "Hypokalemia"
        ],
        "interactions": "Beta-blockers antagonize effects.",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "long-acting-beta-2-agonists-laba",
            "selective-β2-agonists"
        ]
    },
    {
        "id": "terbutaline",
        "name": "Terbutaline",
        "pharmacologicClass": "selective-β2-agonists",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Selective stimulation of β2 receptors causing bronchodilation.",
        "features": "β2 selective, systemic administration. | β2-agonist, off-label use for tocolysis.",
        "clinicalChoice": "Tocolysis and asthma exacerbations.",
        "indications": [
            "Asthma",
            "Preterm Labor"
        ],
        "contraindications": [
            "Cardiac Disease",
            "Hyperthyroidism"
        ],
        "sideEffects": [
            "Tachycardia",
            "Tremor",
            "Hypokalemia"
        ],
        "interactions": "Beta-blockers antagonize effects.",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "selective-β2-agonists",
            "tocolytics"
        ]
    },
    {
        "id": "phenylephrine",
        "name": "Phenylephrine",
        "pharmacologicClass": "nasal-decongestants",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Stimulate α1 receptors causing vasoconstriction and increased tone.",
        "features": "Pure α1 agonist. | Shorter duration, less rebound.",
        "clinicalChoice": "Hypotension, nasal decongestant, mydriasis.",
        "indications": [
            "Hypotension",
            "Nasal Congestion"
        ],
        "contraindications": [
            "Severe Hypertension"
        ],
        "sideEffects": [
            "Hypertension",
            "Reflex bradycardia",
            "Piloerection"
        ],
        "interactions": "MAOIs enhance effects, α-blockers antagonize.",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "nasal-decongestants",
            "α1-selective-agonists"
        ]
    },
    {
        "id": "midodrine",
        "name": "Midodrine",
        "pharmacologicClass": "α1-selective-agonists",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Stimulate α1 receptors causing vasoconstriction and increased tone.",
        "features": "Prodrug activating α1 receptors.",
        "clinicalChoice": "Neurogenic orthostatic hypotension.",
        "indications": [
            "Orthostatic Hypotension"
        ],
        "contraindications": [
            "Severe Organic Heart Disease",
            "Urinary Retention"
        ],
        "sideEffects": [
            "Hypertension",
            "Reflex bradycardia",
            "Piloerection"
        ],
        "interactions": "MAOIs enhance effects, α-blockers antagonize.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "amphetamine",
        "name": "Amphetamine",
        "pharmacologicClass": "indirect-sympathomimetics",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Increase synaptic catecholamines via release or reuptake inhibition.",
        "features": "Promotes release of catecholamines.",
        "clinicalChoice": "ADHD, narcolepsy.",
        "indications": [
            "ADHD",
            "Narcolepsy"
        ],
        "contraindications": [
            "Severe Hypertension",
            "Cardiac Disease"
        ],
        "sideEffects": [
            "Tachycardia",
            "Hypertension",
            "CNS stimulation"
        ],
        "interactions": "MAOIs and sympathomimetics potentiate hypertensive crises.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "ephedrine",
        "name": "Ephedrine",
        "pharmacologicClass": "indirect-sympathomimetics",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Increase synaptic catecholamines via release or reuptake inhibition.",
        "features": "Mixed direct/indirect sympathomimetic.",
        "clinicalChoice": "Nasal decongestant, hypotension in anesthesia.",
        "indications": [
            "Hypotension",
            "Nasal Congestion"
        ],
        "contraindications": [
            "Tachyarrhythmias"
        ],
        "sideEffects": [
            "Tachycardia",
            "Hypertension",
            "CNS stimulation"
        ],
        "interactions": "MAOIs and sympathomimetics potentiate hypertensive crises.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "cocaine",
        "name": "Cocaine",
        "pharmacologicClass": "reuptake-inhibitors",
        "therapeuticClass": "adrenergic-agonists-sympathomimetics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block catecholamine reuptake pumps at synaptic clefts.",
        "features": "Blocks NE reuptake, local anesthetic.",
        "clinicalChoice": "Topical anesthetic for ENT procedures.",
        "indications": [
            "Local Anesthesia"
        ],
        "contraindications": [
            "Beta Blocker Use",
            "Cardiovascular Disease"
        ],
        "sideEffects": [
            "Arrhythmias",
            "Hypertension",
            "Seizures"
        ],
        "interactions": "Sympathomimetics enhance toxicity.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "propranolol",
        "name": "Propranolol",
        "pharmacologicClass": "beta-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block beta-adrenergic receptors, reducing heart rate and contractility.",
        "features": "Non-selective, crosses BBB.",
        "clinicalChoice": "Anxiety, migraine prophylaxis.",
        "indications": [
            "Hypertension",
            "Anxiety",
            "Migraine"
        ],
        "contraindications": [
            "Asthma",
            "COPD",
            "Heart Block"
        ],
        "sideEffects": [
            "Bradycardia",
            "Fatigue",
            "Bronchoconstriction"
        ],
        "interactions": "Calcium channel blockers, amiodarone.",
        "interactionDetails": "MECHANISM: Both beta blockers and calcium channel blockers (especially verapamil and diltiazem) independently suppress cardiac conduction and contractility. Beta blockers block sympathetic stimulation of the heart, while non-dihydropyridine CCBs block L-type calcium channels crucial for cardiac conduction and contraction. CLINICAL CONSEQUENCE: When combined, these effects are additive, creating dangerous negative inotropic (reduced contractility) and negative chronotropic (reduced heart rate) effects. This can lead to severe bradycardia, complete heart block, cardiogenic shock, and hemodynamic collapse. AMIODARONE: Has additional risks due to its multiple mechanisms - blocks sodium, potassium, and calcium channels while also having anti-adrenergic effects, creating a \"quadruple block\" when combined with beta blockers.",
        "pageType": "drug"
    },
    {
        "id": "metoprolol",
        "name": "Metoprolol",
        "pharmacologicClass": "beta-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block beta-adrenergic receptors, reducing heart rate and contractility.",
        "features": "β1-selective (cardioselective).",
        "clinicalChoice": "Hypertension with asthma/COPD.",
        "indications": [
            "Hypertension",
            "Heart Failure"
        ],
        "contraindications": [
            "Decompensated Heart Failure",
            "Heart Block"
        ],
        "sideEffects": [
            "Bradycardia",
            "Fatigue",
            "Bronchoconstriction"
        ],
        "interactions": "Calcium channel blockers, amiodarone.",
        "interactionDetails": "MECHANISM: Both beta blockers and calcium channel blockers (especially verapamil and diltiazem) independently suppress cardiac conduction and contractility. Beta blockers block sympathetic stimulation of the heart, while non-dihydropyridine CCBs block L-type calcium channels crucial for cardiac conduction and contraction. CLINICAL CONSEQUENCE: When combined, these effects are additive, creating dangerous negative inotropic (reduced contractility) and negative chronotropic (reduced heart rate) effects. This can lead to severe bradycardia, complete heart block, cardiogenic shock, and hemodynamic collapse. AMIODARONE: Has additional risks due to its multiple mechanisms - blocks sodium, potassium, and calcium channels while also having anti-adrenergic effects, creating a \"quadruple block\" when combined with beta blockers.",
        "pageType": "drug"
    },
    {
        "id": "atenolol",
        "name": "Atenolol",
        "pharmacologicClass": "beta-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block beta-adrenergic receptors, reducing heart rate and contractility.",
        "features": "β1-selective, renally excreted.",
        "clinicalChoice": "Hypertension, post-MI.",
        "indications": [
            "Hypertension",
            "Post-MI"
        ],
        "contraindications": [
            "Heart Block",
            "Severe Bradycardia"
        ],
        "sideEffects": [
            "Bradycardia",
            "Fatigue",
            "Bronchoconstriction"
        ],
        "interactions": "Calcium channel blockers, amiodarone.",
        "interactionDetails": "MECHANISM: Both beta blockers and calcium channel blockers (especially verapamil and diltiazem) independently suppress cardiac conduction and contractility. Beta blockers block sympathetic stimulation of the heart, while non-dihydropyridine CCBs block L-type calcium channels crucial for cardiac conduction and contraction. CLINICAL CONSEQUENCE: When combined, these effects are additive, creating dangerous negative inotropic (reduced contractility) and negative chronotropic (reduced heart rate) effects. This can lead to severe bradycardia, complete heart block, cardiogenic shock, and hemodynamic collapse. AMIODARONE: Has additional risks due to its multiple mechanisms - blocks sodium, potassium, and calcium channels while also having anti-adrenergic effects, creating a \"quadruple block\" when combined with beta blockers.",
        "pageType": "drug"
    },
    {
        "id": "carvedilol",
        "name": "Carvedilol",
        "pharmacologicClasses": [
            "beta-blockers",
            "alpha-blockers"
        ],
        "pharmacologicClass": "beta-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block beta-adrenergic receptors, reducing heart rate and contractility.",
        "features": "Combined α/β blocker (α1/β1/β2 antagonist).",
        "clinicalChoice": "Heart failure with proven mortality benefit.",
        "indications": [
            "Heart Failure",
            "Hypertension"
        ],
        "contraindications": [
            "Decompensated Heart Failure"
        ],
        "sideEffects": [
            "Bradycardia",
            "Fatigue",
            "Bronchoconstriction"
        ],
        "interactions": "Calcium channel blockers, amiodarone.",
        "interactionDetails": "MECHANISM: Both beta blockers and calcium channel blockers (especially verapamil and diltiazem) independently suppress cardiac conduction and contractility. Beta blockers block sympathetic stimulation of the heart, while non-dihydropyridine CCBs block L-type calcium channels crucial for cardiac conduction and contraction. CLINICAL CONSEQUENCE: When combined, these effects are additive, creating dangerous negative inotropic (reduced contractility) and negative chronotropic (reduced heart rate) effects. This can lead to severe bradycardia, complete heart block, cardiogenic shock, and hemodynamic collapse. AMIODARONE: Has additional risks due to its multiple mechanisms - blocks sodium, potassium, and calcium channels while also having anti-adrenergic effects, creating a \"quadruple block\" when combined with beta blockers.",
        "pageType": "drug"
    },
    {
        "id": "esmolol",
        "name": "Esmolol",
        "pharmacologicClass": "beta-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block beta-adrenergic receptors, reducing heart rate and contractility.",
        "features": "Ultra–short acting β1 blocker.",
        "clinicalChoice": "Acute SVT, intraoperative control.",
        "indications": [
            "Supraventricular Tachycardia",
            "Thyroid Storm"
        ],
        "contraindications": [
            "Sinus Bradycardia",
            "Heart Block"
        ],
        "sideEffects": [
            "Bradycardia",
            "Fatigue",
            "Bronchoconstriction"
        ],
        "interactions": "Calcium channel blockers, amiodarone.",
        "interactionDetails": "MECHANISM: Both beta blockers and calcium channel blockers (especially verapamil and diltiazem) independently suppress cardiac conduction and contractility. Beta blockers block sympathetic stimulation of the heart, while non-dihydropyridine CCBs block L-type calcium channels crucial for cardiac conduction and contraction. CLINICAL CONSEQUENCE: When combined, these effects are additive, creating dangerous negative inotropic (reduced contractility) and negative chronotropic (reduced heart rate) effects. This can lead to severe bradycardia, complete heart block, cardiogenic shock, and hemodynamic collapse. AMIODARONE: Has additional risks due to its multiple mechanisms - blocks sodium, potassium, and calcium channels while also having anti-adrenergic effects, creating a \"quadruple block\" when combined with beta blockers.",
        "pageType": "drug"
    },
    {
        "id": "timolol",
        "name": "Timolol",
        "pharmacologicClass": "beta-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block beta-adrenergic receptors, reducing heart rate and contractility.",
        "features": "Non-selective, ophthalmic use. | Non-selective beta-blocker, twice daily.",
        "clinicalChoice": "Open-angle glaucoma topical therapy.",
        "indications": [
            "Glaucoma",
            "Open-Angle Glaucoma"
        ],
        "contraindications": [
            "Asthma",
            "COPD"
        ],
        "sideEffects": [
            "Bradycardia",
            "Fatigue",
            "Bronchoconstriction"
        ],
        "interactions": "Calcium channel blockers, amiodarone.",
        "interactionDetails": "MECHANISM: Both beta blockers and calcium channel blockers (especially verapamil and diltiazem) independently suppress cardiac conduction and contractility. Beta blockers block sympathetic stimulation of the heart, while non-dihydropyridine CCBs block L-type calcium channels crucial for cardiac conduction and contraction. CLINICAL CONSEQUENCE: When combined, these effects are additive, creating dangerous negative inotropic (reduced contractility) and negative chronotropic (reduced heart rate) effects. This can lead to severe bradycardia, complete heart block, cardiogenic shock, and hemodynamic collapse. AMIODARONE: Has additional risks due to its multiple mechanisms - blocks sodium, potassium, and calcium channels while also having anti-adrenergic effects, creating a \"quadruple block\" when combined with beta blockers.",
        "pageType": "drug",
        "pharmacologicClasses": [
            "beta-blockers"
        ]
    },
    {
        "id": "nadolol",
        "name": "Nadolol",
        "pharmacologicClass": "beta-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block beta-adrenergic receptors, reducing heart rate and contractility.",
        "features": "Non-selective, long half-life.",
        "clinicalChoice": "Portal hypertension variceal prophylaxis.",
        "indications": [
            "Hypertension",
            "Variceal Bleeding Prophylaxis"
        ],
        "contraindications": [
            "Asthma",
            "Heart Block"
        ],
        "sideEffects": [
            "Bradycardia",
            "Fatigue",
            "Bronchoconstriction"
        ],
        "interactions": "Calcium channel blockers, amiodarone.",
        "interactionDetails": "MECHANISM: Both beta blockers and calcium channel blockers (especially verapamil and diltiazem) independently suppress cardiac conduction and contractility. Beta blockers block sympathetic stimulation of the heart, while non-dihydropyridine CCBs block L-type calcium channels crucial for cardiac conduction and contraction. CLINICAL CONSEQUENCE: When combined, these effects are additive, creating dangerous negative inotropic (reduced contractility) and negative chronotropic (reduced heart rate) effects. This can lead to severe bradycardia, complete heart block, cardiogenic shock, and hemodynamic collapse. AMIODARONE: Has additional risks due to its multiple mechanisms - blocks sodium, potassium, and calcium channels while also having anti-adrenergic effects, creating a \"quadruple block\" when combined with beta blockers.",
        "pageType": "drug"
    },
    {
        "id": "nebivolol",
        "name": "Nebivolol",
        "pharmacologicClass": "beta-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block beta-adrenergic receptors, reducing heart rate and contractility.",
        "features": "β1 blocker with NO-mediated vasodilation.",
        "clinicalChoice": "Hypertension with metabolic syndrome.",
        "indications": [
            "Hypertension"
        ],
        "contraindications": [
            "Severe Hepatic Impairment"
        ],
        "sideEffects": [
            "Bradycardia",
            "Fatigue",
            "Bronchoconstriction"
        ],
        "interactions": "Calcium channel blockers, amiodarone.",
        "interactionDetails": "MECHANISM: Both beta blockers and calcium channel blockers (especially verapamil and diltiazem) independently suppress cardiac conduction and contractility. Beta blockers block sympathetic stimulation of the heart, while non-dihydropyridine CCBs block L-type calcium channels crucial for cardiac conduction and contraction. CLINICAL CONSEQUENCE: When combined, these effects are additive, creating dangerous negative inotropic (reduced contractility) and negative chronotropic (reduced heart rate) effects. This can lead to severe bradycardia, complete heart block, cardiogenic shock, and hemodynamic collapse. AMIODARONE: Has additional risks due to its multiple mechanisms - blocks sodium, potassium, and calcium channels while also having anti-adrenergic effects, creating a \"quadruple block\" when combined with beta blockers.",
        "pageType": "drug"
    },
    {
        "id": "labetalol",
        "name": "Labetalol",
        "pharmacologicClasses": [
            "beta-blockers",
            "alpha-blockers"
        ],
        "pharmacologicClass": "beta-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block beta-adrenergic receptors, reducing heart rate and contractility.",
        "features": "α1 and β blockade (mixed α1/β antagonist), IV or PO.",
        "clinicalChoice": "Hypertensive emergency, pregnancy.",
        "indications": [
            "Hypertensive Emergency",
            "Pregnancy Hypertension"
        ],
        "contraindications": [
            "Asthma",
            "Heart Block"
        ],
        "sideEffects": [
            "Bradycardia",
            "Fatigue",
            "Bronchoconstriction"
        ],
        "interactions": "Calcium channel blockers, amiodarone.",
        "interactionDetails": "MECHANISM: Both beta blockers and calcium channel blockers (especially verapamil and diltiazem) independently suppress cardiac conduction and contractility. Beta blockers block sympathetic stimulation of the heart, while non-dihydropyridine CCBs block L-type calcium channels crucial for cardiac conduction and contraction. CLINICAL CONSEQUENCE: When combined, these effects are additive, creating dangerous negative inotropic (reduced contractility) and negative chronotropic (reduced heart rate) effects. This can lead to severe bradycardia, complete heart block, cardiogenic shock, and hemodynamic collapse. AMIODARONE: Has additional risks due to its multiple mechanisms - blocks sodium, potassium, and calcium channels while also having anti-adrenergic effects, creating a \"quadruple block\" when combined with beta blockers.",
        "pageType": "drug"
    },
    {
        "id": "prazosin",
        "name": "Prazosin",
        "pharmacologicClass": "alpha-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block alpha-adrenergic receptors causing vasodilation.",
        "features": "Selective α1-blocker.",
        "clinicalChoice": "Hypertension, BPH, PTSD nightmares.",
        "indications": [
            "Hypertension",
            "BPH",
            "PTSD"
        ],
        "contraindications": [
            "Hypotension"
        ],
        "sideEffects": [
            "Orthostatic hypotension",
            "First-dose syncope"
        ],
        "interactions": "Other antihypertensives (additive effects).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "doxazosin",
        "name": "Doxazosin",
        "pharmacologicClass": "alpha-1-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block alpha-adrenergic receptors causing vasodilation.",
        "features": "Long-acting α1-blocker. | Non-selective α1 blocker.",
        "clinicalChoice": "BPH with hypertension.",
        "indications": [
            "BPH",
            "Benign Prostatic Hyperplasia",
            "Hypertension"
        ],
        "contraindications": [
            "Hypotension"
        ],
        "sideEffects": [
            "Orthostatic hypotension",
            "First-dose syncope"
        ],
        "interactions": "Other antihypertensives (additive effects).",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "alpha-1-blockers",
            "alpha-blockers"
        ]
    },
    {
        "id": "terazosin",
        "name": "Terazosin",
        "pharmacologicClass": "alpha-1-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block alpha-adrenergic receptors causing vasodilation.",
        "features": "α1 blocker with smooth muscle relaxation. | Long-acting α1 blocker.",
        "clinicalChoice": "BPH symptom relief.",
        "indications": [
            "BPH",
            "Benign Prostatic Hyperplasia",
            "Hypertension"
        ],
        "contraindications": [
            "Hypotension"
        ],
        "sideEffects": [
            "Orthostatic hypotension",
            "First-dose syncope"
        ],
        "interactions": "Other antihypertensives (additive effects).",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "alpha-1-blockers",
            "alpha-blockers"
        ]
    },
    {
        "id": "tamsulosin",
        "name": "Tamsulosin",
        "pharmacologicClass": "alpha-1-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block alpha-adrenergic receptors causing vasodilation.",
        "features": "Uroselective α1A antagonist. | Selective for α1A receptors in prostate.",
        "clinicalChoice": "BPH with minimal blood pressure effect.",
        "indications": [
            "BPH",
            "Benign Prostatic Hyperplasia"
        ],
        "contraindications": [
            "Sulfa Allergy"
        ],
        "sideEffects": [
            "Orthostatic hypotension",
            "First-dose syncope"
        ],
        "interactions": "Other antihypertensives (additive effects).",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "alpha-1-blockers",
            "alpha-blockers"
        ]
    },
    {
        "id": "phenoxybenzamine",
        "name": "Phenoxybenzamine",
        "pharmacologicClass": "alpha-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block alpha-adrenergic receptors causing vasodilation.",
        "features": "Irreversible non-selective α blocker.",
        "clinicalChoice": "Preoperative pheochromocytoma preparation.",
        "indications": [
            "Pheochromocytoma"
        ],
        "contraindications": [
            "Angina",
            "Severe Hypotension"
        ],
        "sideEffects": [
            "Orthostatic hypotension",
            "First-dose syncope"
        ],
        "interactions": "Other antihypertensives (additive effects).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "phentolamine",
        "name": "Phentolamine",
        "pharmacologicClass": "alpha-blockers",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Block alpha-adrenergic receptors causing vasodilation.",
        "features": "Reversible non-selective α blocker.",
        "clinicalChoice": "Hypertensive crisis from MAOI/tyramine.",
        "indications": [
            "Pheochromocytoma",
            "Cocaine Extravasation"
        ],
        "contraindications": [
            "Coronary Artery Disease"
        ],
        "sideEffects": [
            "Orthostatic hypotension",
            "First-dose syncope"
        ],
        "interactions": "Other antihypertensives (additive effects).",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "clonidine",
        "name": "Clonidine",
        "pharmacologicClass": "central-α2-agonists",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Stimulate central α2 receptors to reduce sympathetic outflow.",
        "features": "Lipophilic, rapid onset oral/patch.",
        "clinicalChoice": "Resistant hypertension, ADHD adjunct.",
        "indications": [
            "Hypertension",
            "ADHD"
        ],
        "contraindications": [
            "Depression",
            "Severe Coronary Insufficiency"
        ],
        "sideEffects": [
            "Sedation",
            "Rebound hypertension",
            "Dry mouth"
        ],
        "interactions": "CNS depressants enhance sedation.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "methyldopa",
        "name": "Methyldopa",
        "pharmacologicClass": "central-α2-agonists",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Stimulate central α2 receptors to reduce sympathetic outflow.",
        "features": "Converted to α-methylnorepinephrine.",
        "clinicalChoice": "Hypertension during pregnancy.",
        "indications": [
            "Pregnancy Hypertension"
        ],
        "contraindications": [
            "Hepatic Disease",
            "MAOI Therapy"
        ],
        "sideEffects": [
            "Sedation",
            "Rebound hypertension",
            "Dry mouth"
        ],
        "interactions": "CNS depressants enhance sedation.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "tizanidine",
        "name": "Tizanidine",
        "pharmacologicClass": "central-acting-muscle-relaxants",
        "therapeuticClass": "adrenergic-antagonists-sympatholytics",
        "system": "autonomic-nervous-system",
        "mechanism": "Stimulate central α2 receptors to reduce sympathetic outflow.",
        "features": "Imidazoline derivative, muscle relaxant. | α2-adrenergic agonist.",
        "clinicalChoice": "Spasticity management.",
        "indications": [
            "Muscle Spasms",
            "Muscle Spasticity",
            "Spasticity"
        ],
        "contraindications": [
            "Severe Hepatic Impairment"
        ],
        "sideEffects": [
            "Sedation",
            "Rebound hypertension",
            "Dry mouth"
        ],
        "interactions": "CNS depressants enhance sedation.",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "central-acting-muscle-relaxants",
            "central-α2-agonists"
        ]
    }

];export default drugs;
